Ask AI
ProCE Banner Activity

Using Local Data to Optimize Molecular Rapid Diagnostic Tests for Bloodstream Infections

Clinical Thought

When an antimicrobial resistance marker is detected in a blood culture molecular rapid diagnostic test, the path forward is relatively simple: Escalate therapy to target that marker of resistance. But what if no resistance genes are detected? Can this information be used to de-escalate therapy? Here is what I think.

Released: July 10, 2025

Expiration: July 09, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from bioMérieux, Inc.

bioMérieux, Inc.

Faculty Disclosure

Primary Author

Emily Heil, PharmD, MS, BCIDP, AAHIVP, has no relevant financial relationships to disclose.